Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.

Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, et al.

EMBO J. 1993 May;12(5):1929-36.

PMID:
8491186
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.

Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D.

Nature. 1993 May 6;363(6424):83-5.

PMID:
8479540
[PubMed - indexed for MEDLINE]
3.
4.

The role of c-myc in cell growth.

Evan GI, Littlewood TD.

Curr Opin Genet Dev. 1993 Feb;3(1):44-9. Review.

PMID:
8453273
[PubMed - indexed for MEDLINE]
5.

SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.

Pendergast AM, Gishizky ML, Havlik MH, Witte ON.

Mol Cell Biol. 1993 Mar;13(3):1728-36.

PMID:
8441409
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.

Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, et al.

Cell. 1993 Oct 8;75(1):175-85.

PMID:
8402896
[PubMed - indexed for MEDLINE]
8.

Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types.

Satoh T, Fantl WJ, Escobedo JA, Williams LT, Kaziro Y.

Mol Cell Biol. 1993 Jun;13(6):3706-13.

PMID:
8388543
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Control of programmed cell death in normal and leukemic cells: new implications for therapy.

Sachs L, Lotem J.

Blood. 1993 Jul 1;82(1):15-21. Review.

PMID:
8324219
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.

Smetsers TF, Skorski T, van de Locht LT, Wessels HM, Pennings AH, de Witte T, Calabretta B, Mensink EJ.

Leukemia. 1994 Jan;8(1):129-40.

PMID:
8289478
[PubMed - indexed for MEDLINE]
12.

A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.

Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA, Schlessinger J.

Mol Cell Biol. 1994 Jan;14(1):509-17.

PMID:
8264620
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Ash/Grb-2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF.

Matuoka K, Shibasaki F, Shibata M, Takenawa T.

EMBO J. 1993 Sep;12(9):3467-73.

PMID:
8253073
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.

McWhirter JR, Galasso DL, Wang JY.

Mol Cell Biol. 1993 Dec;13(12):7587-95.

PMID:
8246975
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The control of apoptosis in mammalian cells.

Collins MK, Lopez Rivas A.

Trends Biochem Sci. 1993 Aug;18(8):307-9. Review.

PMID:
8236446
[PubMed - indexed for MEDLINE]
16.

Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.

Clarkson B, Strife A.

Leukemia. 1993 Nov;7(11):1683-721. Review.

PMID:
8231240
[PubMed - indexed for MEDLINE]
17.

Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling.

Sato N, Sakamaki K, Terada N, Arai K, Miyajima A.

EMBO J. 1993 Nov;12(11):4181-9.

PMID:
8223433
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Differential complementation of Bcr-Abl point mutants with c-Myc.

Afar DE, Goga A, McLaughlin J, Witte ON, Sawyers CL.

Science. 1994 Apr 15;264(5157):424-6.

PMID:
8153630
[PubMed - indexed for MEDLINE]
19.

bcr/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors.

Laneuville P, Timm M, Hudson AT.

Cancer Res. 1994 Mar 1;54(5):1360-6.

PMID:
8118826
[PubMed - indexed for MEDLINE]
Free Article
20.

BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.

McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG.

Blood. 1994 Mar 1;83(5):1179-87. Erratum in: Blood 1994 Jun 15;83(12):3835.

PMID:
8118022
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk